Scott W Power

US Patent:

6590078, Jul 8, 2003

Filed:

Jul 23, 2001

Appl. No.:

09/912733

Inventors:

Michael Ward - San Francisco CA
Scott D. Power - San Bruno CA

Assignee:

Genencor International, Inc. - Palo Alto CA

International Classification:

C07K 100

US Classification:

530350, 435 697

Abstract:

The invention includes novel fusion nucleic acids encoding fusion polypeptides which when expressed in a filamentous fungus result in the expression of fusion polypeptides. The fusion nucleic acids comprise four nucleic acids which encode a fusion polypeptide comprising first, second, third and fourth amino acid sequences. The first nucleic acid encodes a signal polypeptide functional as a secretory sequence in a first filamentous fungus. The second nucleic acid encodes a secreted polypeptide or functional portion thereof which is normally secreted from the same filamentous fungus or a second filamentous fungus. The third nucleic acid encodes a cleavable linker while the fourth nucleic acid comprises at least two nucleic acids encoding desired polypeptides.

US Patent:

6685748, Feb 3, 2004

Filed:

Apr 4, 2000

Appl. No.:

09/542311

Inventors:

Anthony G. Day - San Francisco CA
Scott D. Power - San Bruno CA
Doreen Victoria - San Francisco CA
Deborah S. Winetzky - Foster City CA

Assignee:

Genencor International, Inc. - Palo Alto CA

International Classification:

D06Q 102

US Classification:

8107, 8101, 811551, 81161, 8401, 162 70, 162 72, 435183

Abstract:

A method is provided for bleaching a non-cotton cellulosic fiber, yarn or fabric by contacting said fiber, yarn or fabric with a hemicellulase enzyme for a time and under conditions suitable to produce a whitening of said fiber, yarn or fabric.

US Patent:

7413877, Aug 19, 2008

Filed:

Nov 8, 2004

Appl. No.:

10/984514

Inventors:

Katherine Collier - Los Altos CA, US
Grant Ganshaw - Tracy CA, US
Hans De Nobel - Almere, NL
Scott D. Power - San Bruno CA, US
Anita Van Kimmenade - San Bruno CA, US
Marc Kolkman - Oegstgeest, NL
Jeffrey Miller - Santa Cruz CA, US
Brian Schmidt - Halfmoon Bay CA, US
Gudrun Vogtentanz - Santa Clara CA, US
David Estell - San Mateo CA, US

Assignee:

Genencor International, Inc. - Palo Alto CA

International Classification:

C12P 29/00
C07H 21/04
C12N 1/21

US Classification:

435 711, 4352523, 43525231, 536 231

Abstract:

The present invention provides compositions and methods related to the expression of Bowman-Birk protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the Bowman-Birk protease inhibitors.

US Patent:

7485618, Feb 3, 2009

Filed:

Nov 8, 2004

Appl. No.:

10/984410

Inventors:

Anthony G. Day - San Francisco CA, US
Christopher J. Murray - Soquel CA, US
Scott D. Power - San Bruno CA, US
Beverley Rider Turnquest - San Jose CA, US

Assignee:

Genencor International, Inc. - Palo Alto CA

International Classification:

A61K 38/08

US Classification:

514 2

Abstract:

The present invention provides peptides and supported peptides that bind to FGF-5.

US Patent:

7507803, Mar 24, 2009

Filed:

Oct 3, 2003

Appl. No.:

10/677754

Inventors:

Alessandro Sette - La Jolla CA, US
Robert Chesnut - Cardiff-by-the-Sea CA, US
Mark J. Newman - Carlsbad CA, US
Brian D. Livingston - San Diego CA, US
Lilia Maria Babe - Emerald Hills CA, US
Yiyou Chen - San Jose CA, US
Lawrence M. Deyoung - Montara CA, US
Manley T. F. Huang - Palo Alto CA, US
Scott D. Power - San Bruno CA, US

Assignee:

Genimmune N.V. - Zwijnaarde

International Classification:

C07H 21/04

US Classification:

536 231

Abstract:

The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.

US Patent:

7524816, Apr 28, 2009

Filed:

Nov 8, 2004

Appl. No.:

10/984270

Inventors:

Anthony G. Day - San Francisco CA, US
David A. Estell - San Mateo CA, US
Christopher J. Murray - Soquel CA, US
Scott D. Power - San Bruno CA, US

Assignee:

Genencor International, Inc. - Palo Alto CA

International Classification:

A61K 38/16

US Classification:

514 12

Abstract:

The present invention provides peptides and supported peptides for treating proliferative diseases. In particularly preferred embodiments, the present invention provides peptides and supported peptides for treating diseases of the skin, such as rosacea. In some particularly preferred embodiments, the supported peptides of the present invention are anti-VEGF peptides. In alternative particularly preferred embodiments, the anti-VEGF peptides are expressed on a scaffold protein. In some most preferred embodiments, the scaffold proteins is BBI.

US Patent:

7696173, Apr 13, 2010

Filed:

Jul 14, 2008

Appl. No.:

12/172921

Inventors:

Katherine Collier - Los Altos CA, US
Grant Ganshaw - Tracy CA, US
Hans De Nobel - Almere, NL
Scott D. Power - San Bruno CA, US
Anita Van Kimmenade - San Bruno CA, US
Marc Kolkman - Oegstgeest, NL
Jeffrey Miller - Santa Cruz CA, US
Brian Schmidt - Halfmoon Bay CA, US
Gudrun Vogtentanz - Santa Clara CA, US
David Estell - San Mateo CA, US

Assignee:

Danisco US Inc. - Palo Alto CA

International Classification:

A61K 38/16

US Classification:

514 12

Abstract:

The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.

US Patent:

7888472, Feb 15, 2011

Filed:

Mar 20, 2009

Appl. No.:

12/408472

Inventors:

Alessandro Sette - La Jolla CA, US
Robert Chesnut - Cardiff-by-the-Sea CA, US
Mark J. Newman - Carlsbad CA, US
Brian D. Livingston - San Diego CA, US
Lilia Maria Babe - Emerald Hills CA, US
Yiyou Chen - San Jose CA, US
Lawrence M. Deyoung - Montara CA, US
Manley T. F. Huang - Palo Alto CA, US
Scott D. Power - San Bruno CA, US

Assignee:

Epimmune Inc. - San Diego CA
GENimmune N.V. - Zwijnaarde

International Classification:

C07K 14/00
A61K 39/00

US Classification:

530350, 4241841, 4242251

Abstract:

The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.